Through MR analysis, a significant association was observed between SGLT2 inhibition and a reduced risk of type 2 diabetes (P = 3.02 × 10−5, odds ratio [OR] [95% confidence interval (CI)] = 0.47[0.33, 0.67]) (Table 1). This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.